Last reviewed · How we verify
NCT04966390
Standardized Clinical Application of Antibacterial/Anitifungal Drugs
trial in Antibiotics in 5,000 participants. Status unknown.
30 June 2022
Quick facts
| Lead sponsor | Peking University People's Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 20 July 2021 |
| Primary completion | 30 June 2022 |
| Estimated completion | 31 December 2022 |
Conditions studied
- Antibiotics — all drugs for Antibiotics →
Sponsor
Peking University People's Hospital
Who can join
18 and older, any sex, with Antibiotics. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this real world study is to observe the clinical status for standardized using of antibacterial/anitifungal drugs in patients with infection,and to evaluate the efficacy and safety of anti-infection therapy.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Machine learning-based prediction of mortality and multidrug-resistant infection risks in ICU patients with suspected infection: a prospective national multicenter cohort study.
Yang S, Sun Y, Wang T, Hao C, et al · · 2025 · PMID 41422100 · DOI 10.1186/s12879-025-12354-8 -
Machine Learning-Based Prediction of Mortality and Multidrug-Resistant Infection Risks in ICU Patients with Suspected Infection: A Prospective National Multicenter Cohort StudyAuthor information
Yang S, Sun Y, Wang T, Zhang H, et al · · 2025 · DOI 10.21203/rs.3.rs-7333649/v1
Verify or expand the search:
- PubMed search for NCT04966390
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Antibiotics
Currently open trials in the same condition.
- NCT07016217 — Evaluation of an Educational Intervention on Antibiotics in Dental Care · NA · active not recruiting
- NCT06708689 — Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments · active not recruiting
- NCT04669717 — Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies · Phase 4 · recruiting
- NCT05052619 — Preventive Therapy of Postoperative Intra-abdominal Infection Based on Serum Lactate Changes · NA · recruiting
- NCT03927079 — Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage · NA · active not recruiting
Other Peking University People's Hospital trials
Trials by the same sponsor.
- NCT07535645 — Baricitinib for Post-HSCT Persistent Thrombocytopenia · Phase 1, PHASE2 · not yet recruiting
- NCT07516002 — Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency · not yet recruiting
- NCT07294339 — A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positiv · NA · not yet recruiting
- NCT07500441 — Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML · recruiting
- NCT07487883 — Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04966390 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University People's Hospital
- Last refreshed: 19 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04966390.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing